Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Cleveland Biolabs, Inc. (NQ: CBLI)
1.610 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Cleveland Biolabs, Inc.
 
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Cleveland BioLabs CEO to Present at Roth Capital 20th Annual OC Growth Stock Conference
February 14, 2008
from Marketwired News Releases
Cleveland BioLabs Announces Annual Meeting
February 08, 2008
Retains Michael Kurman, MD as Chief Medical Officer; Yakov Kogan, Ph.D. Appointed Chief Operating Officer Read More
from Marketwired News Releases
Cleveland BioLabs CEO to Share Ongoing Development Strategy at BIO CEO and Investor Conference
February 07, 2008
from Marketwired News Releases
Beacon Research Issues TraderNotes on FEED, WRSP, AUXL, CBLI, ABFS
January 29, 2008
from PR Newswire
Cleveland BioLabs (CBLI) Sees Upside Action
January 28, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3296955 for the full story. Read More
from StreetInsider.com News Articles
CFB By-Products made Simple and Cost Effective, by LA Ash, Inc
January 21, 2008
LA Ash Incorporated is a premier marketer and transporter of fly and bed ash products that remain after coal-fired and coke-fired Circulating Fluidized Bed (CFB) processes in power plants. The success... Read More
from Industry Today
Unusual 11 Mid-Day Movers 1/04: NPTE, SEED, NG Higher; CBLI, ACAT, MCRL, GPN Lower
January 04, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3240485 for the full story. Read More
from StreetInsider.com News Articles
Mid-Day Report
January 04, 2008
Rising unemployment sent the markets tumbling during the midday with the Dow plunging 148 points to 12,909. Nasdaq plummeted 61 points to 2542. Read More
category Market News
from MarketMinute.com Market Updates
Pre-Open Movers: Cleveland BioLabs (CLBI) Sinks, Osiris (OSIR) Soars On DoD Contract News; Arctic Cat (ACAT) Down On Guidance
January 04, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3239518 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs (CBLI) Treatment Not Accepted for DoD Award
January 04, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3239184 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs Not Selected for Defense Contract Award
January 04, 2008
Company to Host Conference Call to Discuss Ongoing Development Strategy for Pipeline of Compounds Read More
from Marketwired News Releases
Cleveland BioLabs to Postpone Year-End Update Conference Call
December 17, 2007
Business on Track to Achieve Objectives Read More
from Marketwired News Releases
Cleveland BioLabs Recaps Development of Lead Compounds and Affirms Confidence in Competitive Position for Department of Defense Contract
December 13, 2007
Company to Host Year-End Update Conference Call December 17 at 10:00 a.m. EST Read More
from Marketwired News Releases
Cleveland BioLabs Protectan CBLB612 Outperforms Market Leading Hematopoietic Stem Cell Stimulator in Mouse Study
December 12, 2007
Demonstrates Potential Breakthrough for Minimally Invasive and More Effective Blood Stem Cell Collection Read More
from Marketwired News Releases
Cleveland BioLabs (CBLI) Said Protectan CBLB502 Effective For Post-Radiation Exposure In Study
December 04, 2007
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3171166 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs Achieves Recovery From Neutropenia and Thrombocytopenia in Primates 48 Hours Post-Irradiation With Protectan CBLB502
December 04, 2007
Demonstrates Potential for Radiation Antidote Stockpiling Read More
from Marketwired News Releases
Cleveland BioLabs Launches Phase II Advanced Renal Cell Carcinoma Trial for Curaxin CBLC102
November 26, 2007
Oral Compound With Historical Safety Profile; Currently in Phase II Trial for Hormone-Refractory Prostate Cancer Read More
from Marketwired News Releases
Cleveland BioLabs to Present at 19th Annual Piper Jaffray Health Care Conference
November 15, 2007
from Marketwired News Releases
Cleveland BioLabs Founding Partner Cleveland Clinic Receives Department of Defense Grant to Study Protectans CBLB502 and CBLB612 for Tourniquet and Other Battlefield Uses
November 09, 2007
from Marketwired News Releases
Cleveland BioLabs Celebrates Opening of Corporate Headquarters Building
October 25, 2007
from Marketwired News Releases
Cleveland BioLabs to Present at Rodman & Renshaw 9th Annual Healthcare Conference
October 22, 2007
from Marketwired News Releases
Cleveland BioLabs Completes Manufacturing Process for Protectan CBLB502
October 18, 2007
Pending Contract Decision From Department of Defense Read More
from Marketwired News Releases
Wallst.Net (www.wallst.net) Updates The Investment Community Through All-New Interviews With SEAP, DDUP and CBLI
September 04, 2007
from PR Newswire
Cleveland BioLabs to Present at Roth Capital Partners 2007 New York Conference
August 28, 2007
from Marketwired News Releases
Cleveland BioLabs Announces Upgrade of Listing to NASDAQ Global Market
August 27, 2007
from Marketwired News Releases
Cleveland BioLabs to Present at Noble Financial Conference
August 14, 2007
from Marketwired News Releases
European Journal of Immunology Paper Highlights Newly Discovered Properties of Cleveland BioLabs' Curaxin CBLC102
August 06, 2007
Suggests Additional Applications for Phase II Anti-Cancer Compound Read More
from Marketwired News Releases
Cleveland BioLabs to Present Protectan CBLB502 at 2007 BARDA Industry Day
July 25, 2007
Department of Defense RFP Decision Expected in Late 2007 Read More
from Marketwired News Releases
Cleveland BioLabs Submits Responses to Two Requests for Information From Department of Health and Human Services and National Institute of Allergy and Infectious Diseases
July 17, 2007
Addresses Requests for Medical Countermeasures for Neutropenia and Thrombocytopenia Arising From Acute Radiation Syndrome Read More
from Marketwired News Releases
Cleveland BioLabs Set to Join Russell Microcap Index
June 12, 2007
from Marketwired News Releases
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here